A severe deficiency of ADAMTS13 activity leads to thrombotic thrombocytopenic purpura (TTP), a specific thrombotic microangiopathy (TMA) characterized by neurologic and cardiac involvement [19–21]. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.